πŸ‡ΊπŸ‡Έ FDA
Patent

US 11938226

Abiotic anti-VEGF nanoparticle

granted A61KA61K31/704A61K31/785

Quick answer

US patent 11938226 (Abiotic anti-VEGF nanoparticle) held by The Regents of the University of California expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/704, A61K31/785, A61K31/795, A61K9/0019